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ABSTRACT 
 The use of wearable technologies in the medical field has several advantages to both 
the patient and the system itself. It allows constant monitoring, providing insightful data about 
patient’s health, which can help the physician make a more accurate diagnosis. Moreover, it 
can potentially reduce healthcare costs that have been constantly increasing due to population 
ageing and, consequently, the increase of chronic diseases prevalence.  
 Despite the advantages, the overall market for wearable technologies is considered to 
be in a critical point since there is no adoption by early majorities. There are several challenges 
that need to be overcome and are especially related to data management and the comfort of 
using such devices.  
 In order to succeed, the industry needs to cross the chasm in which it stands. The study 
of the innovation profile of this industry can help understand its current status and if there is 
a technological opportunity underexploited. These studies can be performed by using a patent 
portfolio and analysing it in order to obtain information about innovation trends in a given 
sector. In this study, a new technology forecasting technique is presented. It is proposed that 
the combined analysis of patent pools and product portfolios can produce insights about 
innovation, potentially uncovering patent vacuums associated with product features. As an 
illustration, the current patent landscape in the wearable medical devices is investigated, 
particularly for wearable electrocardiography (ECG) devices. Through this combined analysis, 
we shed light into the intellectual property strategy in the wearable devices industry. The 
innovation dynamics is also addressed and future avenues for product evolution are pointed 
out. 
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1. INTRODUCTION 
1.1 MOTIVATION 
Wearable devices (WDs) have many different fields of application such as healthcare, 
security, fashion, etc. Nowadays, one of the major reasons that leads customers to buy such 
devices is related to their use both in sports performance (for measuring stamina, for example) 
and fitness (for counting steps, measuring caloric expenditure, etc.).  
The use of wearable devices in the medical context has benefits not only for the patient 
but also for the healthcare system. In one hand, wearable medical devices (WMDs) are related 
with preventive medicine, a key point in reducing healthcare expenses [1], [2], on the other, 
they allow continuous patient monitoring, thus helping in the diagnosis and prescription of a 
personalized treatment for each patient [2]. An illustration of the use of WMDs is the monitoring 
of the cardiovascular system through ECG (electrocardiography) technology [3], [4]. The impact 
of cardiovascular diseases is increasing both in terms of mortality and morbidity, especially in 
developed countries. Consequently, there is a need for continuous monitoring systems that 
allow patients and physicians to evaluate the performance of the cardiovascular system [3]. 
Nevertheless, wearable devices, including the ones using ECG technology, face many different 
challenges that have delayed their adoption by the majority of the population. As a result, the 
overall market for these devices is considered to be at a critical point since it is in a chasm – 
there is a disconnection in adoption between early adopters and early majorities. This lack of 
adoption is caused by an extreme diversity of WDs, which is a result of a quick technological 
growth, causing confusion among customers, affecting their buying decision [5].    
Therefore, in order to understand the technological dynamics of this sector, the need 
for analyzing innovation in the wearable medical devices industry becomes evident.  
Furthermore, such analysis may inform about product design choices, new business model 
adoption and development roadmaps, which can, in turn, promote product adoption [6]. 
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Innovation analysis can be done resorting to multiple sources of data including, among 
others, surveys, sales data or scientific publications [7]. Patents have also been used as data 
source for this analysis, due to their widespread availability and the technical information they 
contain [8]. Moreover, it is worth noting that, according to Grupp and Schmoch, ”Private or 
corporate research generally produces patents rather than academic publications” [9]. Patent 
analysis has been used in several studies that resulted in insightful information about the 
investigated field. By designing a landscape of patents in the industry of wearable medical 
devices, it should be possible to identify underexplored technology opportunities, competitors 
and innovation trends. This information can potentially help investors and analysts to cross the 
chasm that exists in this industry. 
In this work, our focus towards the analysis of innovation in WMDs will be relying on 
patent analysis and product characteristics analysis. Patent analysis can provide answers to 
many different questions allowing to understand which companies are present in the industry, 
what are the countries where innovation in the sector is being performed, what is the potential 
of R&D, etc. [10]. Thereby, different aspects of the dynamics of the innovation process can be 
mapped, such as co-operation in research, technology diffusion across countries or industries 
alongside with studies of the competitive process [11]. However, nowadays, the methods for 
patent analysis (e.g. text mining techniques) rely mostly on conjoint analysis of patent pools 
and patent pool visualization methods, overlooking what is already in the market (e.g. [5], 
[12]). To address this problem, we propose a new method for analysing patents consisting on 
crossing patent claims and related product features in order to understand the 
commercialization dynamics in the wearable technology market, focusing on ECG technology.  
 
1.2 GOALS AND METHODOLOGIES 
The main purpose of this work is to obtain information about the innovation profile of 
WMDs industry through the use of a new proposed method of patent analysis. Particularly, our 
main research goal is to understand whether this industry uses patents and if they are 
promoting or hindering innovation. A secondary objective to this work is to understand how the 
patents in this industry are related to certain product features, eventually uncovering technical 
areas that still have patenting space. As a surrogate for the wearable medical devices industry, 
we will use the ECG wearables.  
The present work is organized in eight different chapters. First, we focus on the 
evolution of wearable technologies giving a special attention to wearable medical devices, ECG 
technology and the social and economic impact that result from their use. Then, different 
methods for innovation studies will be presented, highlighting the advantages and 
disadvantages of using patent analysis. We continue by presenting the proposed method, and 
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then we will present the results, showing the insights that the new proposed method can 
produce, illustrated by its application to the wearable devices industry. The next chapter 
focuses its attention on the interpretation of the obtained results, alongside with a critical 
analysis of the proposed method. We finished by drawing conclusions related to the innovation 
in the WMDs industry. 
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2. WEARABLE TECHNOLOGY 
Wearable technology is not a novelty. Its use can vary from the medical industry to 
military, security or even fashion. In this chapter, an exhaustive analysis of the background of 
wearable devices is made with a particular focus on wearable medical devices. A market 
characterization is also performed, further analyzing both social and economic impacts of the 
adoption of these technologies for healthcare. 
 
2.1 WEARABLE TECHNOLOGIES  
Wearable technology isn’t a new concept or phenomenon [13]. Historically, the use of 
wearable technologies dates back to the use of watches which, with the new digital era, 
evolved. New features were added, like calculators, timers or even calendars, allowing the 
fabrication of small and portable multi-function devices [14]. As soon as internet expanded 
alongside with new discoveries in the field of engineering, these devices acquired new 
characteristics, being also able to recognize users’ state and perceive the environment 
surrounding them without interfering with their daily activities [15]. Therefore, and according 
to their role, they can perform different basic functions like sense, process, store, transmit or 
apply signals. Figure 2.1 is a schematic representation of this type of functions, between the 
device and the location where data is being treated (remote location) [16].  
Nowadays, wearable technologies range from wristbands to smart watches or clothes 
and have the capability of being connected all the time [14]. As shown in figure 2.2, there are 
plenty of activities that benefit from the use of wearables. The different sectors that benefit 
from these technologies are related to security, communication, sport/fitness, lifestyle 
computing, health among others. In a review of wearable technologies, Park and colleagues 
[16] give also some examples of the use of wearable technologies. They state that WDs can be 
used to guarantee first responders safety and to monitor both their physical conditions and the 
environment surrounding them. WDs can also help in elderly care, by monitoring their health 
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and well-being, providing information to other people, for example, to their physician or 
relatives. Many different examples are given, but they all have in common the value that can 
be delivered not only to users but also to the people accessing the recorded data [16]. 
 
 
  
 
 
 
 
 
  
 
Figure 2-1 - Different Interactions between the individual and the Wearable Technology. Available on 
[16] 
 
 
Figure 2-2 - Different uses of wearable technologies. Available on [50], [2] 
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Thus, wearable technologies can be considered as external devices that can be, in some 
way, integrated into users’ outfit or can be worn as an accessory [17]. In 1998, a three category 
definition, as stated in table 2.1, was also suggested, considering the existing products and 
prototypes [18].  
 
Table 2-1 - Category Definition of Wearable Technology. Adapted from [2] and [6]. 
Category Definition 
Wearable Computers  Computing device that is able to be carried on the body, having 
the user interface ready for use.  It allows input and output 
through the use of qwerty-keypads, special keying devices, 
joysticks and graphic interfaces, like LCD-displays. Feedback is 
also possible with sound or vibration. It can be reprogrammed or 
reconfigured for different tasks, including adding or removing 
hardware. 
Wearable Electronics Unlike wearable computers, wearable electronics are simpler and 
set with specific tasks. Compared to mobile devices, their 
appearance is different and are especially designed to be used on 
the body. 
Intelligent Clothing To be considered intelligent, a piece of cloth needs to add some 
feature that is traditionally unclothing-like to the garment. It 
cannot compromise other specific characteristics like wearability 
and washability.  
 
Wearables can be classified in many different ways. According to their functionality, 
they can be single or multi-functional, active or passive, invasive or non-invasive, communicate 
in a wired or wireless mode and be disposable or reusable. Finally, they can be classified 
according to their field of use, like public safety, entertainment, military or position tracking. 
Our main focus will be on wearable technologies applied to the healthcare area, also known as 
WMDs [16]. 
 
2.2 WEARABLE MEDICAL DEVICES 
In recent years, the total amount of healthcare expenses, expressed as a proportion of 
the gross domestic product, is considered to have reached extremely high values. This is a 
consequence of not only an increase in healthcare costs but also a result of an overall economic 
slow-down [19].  These high values, alongside with the ageing of population, [2] are generating 
a new trend in the delivery of healthcare, changing the healthcare delivery setting from 
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hospital to home. Consequently, the relevance of personal healthcare is rising dramatically 
[20] which, in turn, is catalyzing the development of WMDs. According to Hung and colleagues 
[21], the aging of the world’s population leads to an increasing need for both chronic and 
geriatric care. Chronic diseases are becoming the leader cause of both death and disabilities 
and will reach an alarming value by the year of 2020, accounting for about three-fourths of all 
deaths. This includes cardiovascular disease, diabetes, hypertension, etc. Innovation in WDs, 
in this case for home care, allows long-term, continuous and unobstructed monitoring of many 
different biosignals.  A further analysis of different devices and its impact will be made in 
section 2.4. 
 Many different discoveries and developments enabled the progress of wearable 
medical devices and are mainly related to advances made in the field of engineering. The major 
breakthroughs are related to: 
- Sensors coupled to microelectronics, telecommunication and data analysis; 
- Battery technology;  
- Telemedicine; 
- Smartphones, apps and cloud services; and consequent 
- Communication platforms.  
The first breakthrough that was referred is directly related to vital signs monitoring 
since these measurements are usually made by sensors. Developments in this area allowed the 
creation of portable and wearable monitoring systems, using micro sensors that are able to be 
used in fabric. Also, the development and further extensive use of smartphones and apps made 
people more responsive to connectivity features, hence to the phenomenon of staying 
connected, deeply related to continuous monitoring of health signs. Data exchange was 
potentiated with developments related to cloud services [2]. Giuseppe and colleagues [22] 
state that WMDs “normally incorporate noninvasive physiological sensors, data processing 
modules, medical feedback, and wireless data transmission capabilities. They are small, light, 
unobtrusive, and designed for operation by unskilled users.”  
According to the European Council Directive, a medical device is “any instrument, 
apparatus, appliance, software, material or other article” designated to be used for human 
beings, with the goal of:  
- Diagnosis, monitoring, treatment, alleviation of or compensation for an injury 
or handicap, 
- Investigation, replacement or modification of the anatomy or of a physiological 
process,  
- Conception control 
and it is not used “in or on the human body by pharmacological, immunological or metabolic 
means, but which may be assisted in its function by such means” [23]. A WMD can then be 
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defined as “a device that is autonomous, that is noninvasive, and that performs a specific 
medical function such as monitoring or support over a prolonged period of time.” [20] 
Nowadays, most common WMDs are related to monitoring of vital signs like heart rate or blood 
pressure or even to monitor human posture and kinematics with accelerometers [2]. The 
different applications, according to [14], are listed below: 
- Vital signs monitoring (ECG, EEG and EMG);  
- Safety monitoring;  
- In vivo implants;  
- Chronic disease monitoring;  
- Home rehabilitation;  
- Assessment of treatment efficacy;  
- Early detection of disorders;  
- Obesity control.  
 
When designing a WMD there are some challenges that must be faced in order to 
potentiate its acceptance. The first one is related to the wearability of the device and its 
ergonomics. It should allow freedom of movement and it should interfere the minimum in user’s 
life. Regarding technical considerations, it has to be safe and reliable. WMDs usually have to 
collect data, process signals and store/process information so these are features that also need 
to be considered. If information is collected, the WMD must also ensure privacy and security of 
the collected data. It is important for the device to have a feedback mechanism, especially if 
it is going to be used for monitoring. Finally, power consumption must also be considered [20].  
 
2.3 MARKET CHARACTERIZATION  
According to Transparency Market Research, WMDs can be segmented into two different 
groups, namely diagnose and therapeutics. The first one is based on product types and includes 
devices like vital signs monitors, neuromonitoring devices and fetal and obstetric devices. The 
second one can be divided according to the product type or according to the application, like 
remote patient monitoring and home healthcare [24].  
Currently, the market for wearable devices has been focused on consumer electronics 
trying to fulfill the needs of specific customer segments like athletes or fitness consumers  [25]. 
High acquisition costs and motivation are two of the factors that might influence the adoption 
of WDs, narrowing customers segments. In spite of only 1% to 2% of US population has used 
these devices, annual sales are expected to grow more than $50 billion until 2018 [26]. In the 
specific case of medical devices, that can be worn or used at home, the market segment has 
increased in the past years, however, this growth has not decreased hospital care. One can 
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infer that medical devices are acting more like complementary devices instead of acting like 
alternatives to hospital equipment [20]. Nevertheless, healthcare consumers are more 
informed and empowered than ever. Nowadays, people who are connected use several digital 
tools in order to take control of the healthcare service they are using. For example, over 70 % 
of Americans with access to the Internet use it in order to obtain information related to 
healthcare and more than 40% try to diagnose themselves before confirming it with their 
physician. Patients want to balance the value of cost-effective prevention with expensive 
treatments, demanding more information that can be given by WMDs, influencing adoption 
rates [27]. 
According to a forecast [28] that analyzes the global wearable healthcare market, in 
2015 this market was worth $3.3 billion and it is expected to grow at a compound annual growth 
rate (CAGR) of 17,7 %, going to be worth approximately $7,8 billion by 2020. They state that 
the “market is showcasing evident potential in the current context.” Furthermore, they still 
refer that wearable medical devices offer solutions not only to the physicians but also to 
healthcare providers. They categorize them into four different segments: 
- Disease Management; 
- Monitoring and Feedback (more than 70% of all the wearable devices market); 
- Rehabilitation; 
- Health and Fitness processes. 
Another major indicative of the potentials of this market is the investment that venture 
capitalists made in digital health and wearable tech. In 2014 health startups raised more money 
(about $2.3 billion more) than in 2013. A significant share of the money was invested in digital 
medical devices like wearables. As they become cheaper and more sophisticated it is expected 
that these devices and the corresponding apps will become a part of both consumer’s life and 
the healthcare system [29]. However, like any other innovative product, the success of 
wearables depends on many different factors related to the user itself. According to Park and 
colleagues [16],  
The success of any innovative product in the marketplace depends on:  
- Its effectiveness in successfully understanding the user’s needs and meeting 
them; 
- Its compatibility with or similarity to existing products or solutions; 
- The extent of behavioral change needed to use the new product; 
- The reduction in the cost of current solutions or technologies it aims to 
supplant; 
- The improvement in the quality of service (or performance); 
- The enhancement of the user’s convenience. 
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Therefore, the final frontier of wearables lies in demonstrating their value to both the 
end user and the ones paying for the technology. Figure 2.3 presents the interactions alongside 
with other key activities and stakeholders that need to be considered in order to potentiate 
the commercialization process. In the specific case of WMDs, the end user is usually the patient 
and the payer can be a healthcare insurance company.  
 
  
 
 
 
 
 
 
 
 
There are also specific characteristics that make this type of technologies so desirable, 
such as mobility, compactness and portability. Figure 2.4 indicates the main factors that 
influence both the adoption and buying decision of wearable technologies. 
 
Besides what was previously mentioned, the market will only succeed if it is able to 
overcome some challenges that are mainly related to data collection. This data that is being 
Figure 2-4 - Major factors that have impact in the adoption and buying decision of wearables. Available 
on [30]. 
 
 
Figure 2-3 -Key activities and stakeholders in the process of commercialization. Available on [4]. 
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collected at every moment must have a proper analysis, otherwise, it will be useless for the 
user or for the physician. According to Rajan [30], the demand for real-time, insightful and 
actionable data will drive the market faster.  
 
2.4 SOCIAL AND ECONOMIC IMPACT   
Wearables can be the key to change and disrupt the current state of healthcare by 
“eliminating waste, improving patient care, and rationing of reimbursement models” in order 
to “integrate reliable patient data that can be linked in real time across the continuum of care 
and support providers’ decision-making”. This kind of technology is expected to facilitate data 
sharing, potentiating connectivity between healthcare players [31].   
According to a study performed by Morgan Stanley [31], the three main market areas 
that can benefit from the use of wearable devices are: 
- medical device integration and innovation; 
-  employer-sponsored health programs; and 
-  pharmaceutical compliance.  
Medical device integration and innovation are related to the use of these technologies 
in existing technologies and the improvement of existing methods that can potentially benefit 
the patient. In the managed care business, a driver for wearable adoption is the use of 
employer-sponsored health programs that offer a lower healthcare cost for both the consumer 
and employer. In this case, some sort of incentive is made in order to encourage healthier 
workplaces. Nowadays, these programs can include rewards of up to 30% of the healthcare 
coverage and use wearables in order to monitor employees. Regarding pharmaceutical 
compliance, there is an estimation that in the US about 20-30% of the written prescription are 
not filled. In addition, about 50% of all the pharmaceutical treatments are not completed by 
the patient. Therefore, patient compliance is a major limitation of the effectiveness of 
therapies based on pharmaceuticals. There are currently some solutions that are especially 
useful for the elderly that combine pills with small ingestible sensors. This way, a drug 
administration pattern can be recreated since there is an activation of the sensor when the pill 
is ingested, ensuring the physician or a relative that the prescription was followed [31]. 
Another major opportunity is related directly to consumer health and preventive 
medicine, a key point in reducing healthcare costs. As stated before, the conventional hospital-
centered system focused on diagnosis and treatment is now shifting to a new paradigm, i.e., 
healthcare systems focused on the individual. Furthermore, in the long term, wearables can 
change patient management with new monitoring devices in order to optimize the treatment 
of different diseases, like obesity and heart diseases and other chronic diseases. As previously 
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referred, the number of patients with chronic diseases has increased in the past years. These 
diseases are propelling the transformation of healthcare systems due to the need of monitoring 
patient’s health in order to adjust the treatment to their symptoms. Wearable technology is 
recognized as an enabler since it allows individual and home monitoring [2]. Philips, a leading 
healthcare devices provider, states that homecare monitoring can potentially reduce 38% of 
hospital visits and can potentially save $27 000 of the cost per patient per year (in the US) [31].  
According to Michael Davies [1], 
 
“By providing a more complete picture of patients' health, wearable devices 
could also help cut healthcare costs as providers utilize preventive measures 
more effectively. (…) Wearable devices could also provide holistic health data to 
patients as well as clinicians. Empowering patients by providing them with 
access to data that they can understand and affect can increase adherence to 
other preventive behaviors. This is good for health outcomes in general, and it 
could be cost-effective in other areas, too. Wearables can enable social 
motivation and engagement (...)” 
 
The impact of these devices can be exemplified in some of the following cases. In the 
specific case of diabetes, wearable technology is making an impact in the field of therapeutics 
with a wearable device that has a reservoir of insulin that lasts for three days, replacing syringe 
or pen administration. Accurate blood monitoring is also essential for a diabetic patient. 
Nowadays there are continuous glucose monitoring devices that give patients real-time 
information about the levels of glucose. The device consists of an adhesive patch that has a 
small sensor inserted below the skin [31]. Teng and colleagues [2] focus their attention on 
devices that enable disease management, for example, cardiovascular or neurological diseases, 
like congestive heart failure and Parkinson’s disease. The management of these diseases is 
dependent on early detection and a quick response to changes in the patient’s status. For this 
purpose, they give the example of systems of sensors that can be comprised into devices 
embodied in clothes, watches or finger rings. Then, the signals collected by the sensors are 
sent to the healthcare provider. Regarding Parkinson’s disease, they also state the impact that 
these devices can have in assessing information about tremor since the information that is given 
by patients does not reveal accurately the severity of their symptoms. Regarding monitoring, 
some devices are already quite common, like portable ECG systems and blood pressure 
measurements systems. However, there are some new technologies that use as basis the 
principles in these technologies alongside with wearable technologies principles. Lukowicz and 
Troster [15] refer as an example a wrist-worn medical monitor and alert system for the use of 
cardiac and respiratory patients. They also refer the positive impact that wearable technology 
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can have in pain management, linking the amount of activity to the degree of pain felt by the 
patient.  
So, wearables are capable of providing long-term information about the overall health 
of a patient. The development and adoption of smart wearables that are able to collect 
meaningful patient data allow providers and payers to save money by enabling patient 
engagement and preventive care. They also have the ability to empower patients by providing 
them data about their own health. However, many different manufacturers focus their 
attention on the design of wearables for consumers and not for the medical market. This leads 
to the limitation of functionality of these devices that need to track more biosignals in order 
to provide more meaningful data [1]. Nevertheless and according to PWC [29], wearables can 
improve efficiency, productivity, service and engagement across different industries. In the 
specific case of the healthcare industry, they state that it can improve access to medical 
information, increase clinical trial participants, ensure a better diet and exercise and enable 
more accurate diagnosis. 
 
  
2.5 THE SPECIFIC CASE OF ECG TECHNOLOGY  
In developed countries, the impact of some cardio-vascular diseases like myocardial 
infarction and congestive heart failure has increased, increasing mortality and morbidity. 
Consequently, there is a demand for long-term continuous monitoring of a patient’s ECG, 
enabling the evaluation of the performance of the cardiovascular system. The ECG signal is a 
parameter that can be accessible by placing electrodes on the patient’s body [3] and it is one 
of the most used signals for non-invasive diagnosis of different cardiac diseases [4]. According 
to the American Heart Association [32], an ECG is a test that can measure the electric activity 
of the heartbeat. In each beat, an electric impulse travels through the heart causing it to 
squeeze and pump blood.  
 
2.5.1 HEART PHYSIOLOGY AND THE ECG 
The heart is composed by four separate compartments or chambers. There are two 
upper chambers, one in each side of the heart called atrium. They receive and collect blood 
coming to the heart. Then, the atrium delivers blood to the lower chamber, called ventricle, 
which pumps blood away from the heart through rhythmic contractions [33]. Cardiac cells are 
electrically polarized in their resting state. This means that their inside is negatively charged 
compared to the outside. Membrane pumps allow to maintain this polarity by ensuring a right 
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ion distribution. However, these cells can lose their negativity in a process named 
depolarization that is considered to be one of the fundamental electrical events of the heart. 
The depolarization is propagated from cell to cell producing a wave of depolarization that 
represents a current and can be detected by using electrodes. After this event, cells repolarize, 
restoring their resting state. This phenomenon can also be detected through electrodes. The 
waves registered in an ECG are nothing but the manifestation of these two different processes 
[34]. Each portion of the heartbeat, as we can see in figure 2.5 corresponds to a different 
deflection on the ECG. In a normal ECG five visible forms are registered, namely [35]:  
 P wave – Representing the atrial depolarization; 
 Q wave – Representing septal depolarization; 
 R wave – Representing early ventricular depolarization; 
 S wave – Representing late ventricular depolarization; 
 T wave – Representing the repolarization of ventricles. 
 
 
 
 
 
 
 
2.5.2 WEARABLE ECG TECHNOLOGY 
As stated before, continuous monitoring of the ECG activity and activity status can be 
crucial in managing heart related diseases [36] and it can also help in reducing the costs of 
healthcare expenses [37]. Traditional solutions like Holter monitors are not convenient to wear 
since they require too many electrodes attached to the body and are quite heavy. It becomes 
evident that a continuous monitoring system should interfere the minimum in its user lifestyle. 
According to Miao and colleagues [36], there is an increasing demand for small-size, compact 
and wearable ECG acquisition systems. Deepu and colleagues [37] add that the main challenge 
in building a remote monitoring system is the development of compact, low power wearable 
sensors that can acquire, process and transmit the sensed signals to the monitoring device. It 
is required a high level of integration in order to minimize both costs and size of the sensor. 
Wireless transmission technologies can also play an important role in the development of a 
wearable ECG system by replacing all the wired connections with a simple gateway in order to 
Figure 2-5– A graphical representation of the ECG waves. Available on [85]. 
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transmit the information of the biomedical signal [38]. When designing a wearable ECG monitor 
system, according to Meda and Manjunath [39], there are three main factors that should be 
satisfied: a high throughput, wearability and low power consumption. Geethika and Manjunath 
[40] state that a wireless wearable ECG system should include: a monitored object (lead lines 
included), a monitor, wireless modules and a mobile phone/PC with GSM/GPRS/CDMA module. 
These based wireless communications enable the transmission of ECG signals. The device has 
also to store data and perform preprocessing of the acquired signal [41]. Using the user manual 
of one wearable product that used ECG technology as an illustration [42] it is also possible to 
understand what are the  main specifications that these products require. They are especially 
related with performance characteristics, circuitry, output, power requirements, physical 
characteristics, environmental specifications and user interface. 
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3. PATENTS 
In this section, an overview of patents will be made by exploring definitions, contents 
and different classifications. Alongside with this overview, it will be presented the motivation 
behind the study of patents and the outputs of this analysis, focusing on the link between 
patent analysis and extrapolations about innovation trends. 
 
3.1 PATENT OVERVIEW 
Patents are public documents [43] designed to protect inventions or technologies [44]. 
According to the World Intellectual Property Organization (WIPO), a patent allows its owner to 
decide if the invention, that can be a product or process, can or cannot be commercially used 
and by whom the commercialization will be made. The protection, in norm, lasts for twenty 
years and it is valid for the country where it has been granted. 
In order to be protected by a patent, an invention must follow three key criteria, 
namely [45]:  
- It must introduce some new technical content that is not known in the field; 
- It cannot be evident, i.e., for someone skilled in the technical field, the 
new solution cannot be obvious; and 
- It should be possible to use (or be generated) in an industrial context. 
Moreover, as a result of international conventions, other criteria can be applied, such 
as: 
- The new invention must be patentable according to the local law of the 
country in which the patent is being granted since it is the State that gives 
monopoly for commercial exploitation; and 
- The disclosure of the invention has to obey to established rules. 
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Regarding patentability, an invention that consists of materials that already exist in 
nature, scientific theories, plants/animals or even medical treatments/diagnose for human or 
animal use might be excluded from patent protection [45]. 
Regulation on patents states that an application must contain, among others, a 
description of the invention, patent claims, an abstract and, if needed, drawings referring to 
the description [46]. The patent’s data can be divided into two groups: structured and 
unstructured items. Structured items are those which are consistent in both semantics and 
format  [47]. Contrarily, unstructured items don’t have a fixed formatting [48]. The different 
contents of a patent according to the Patent and Trademark Office (PTO) are presented in 
table 3.1. 
 
Table 3-1 - Fields/sections of patents and corresponding description. Adapted from [49] 
Section/Field Description 
Title Name or title of invention. 
Inventor Information Inventor’s identifying information like name 
and address. 
Patent Number Number assigned to the patent. 
Patent Filling Date Corresponds to the date the patent was filled 
by the Patent Office. 
Patent Issue Date Corresponds to the date the patent was 
issued by the Patent Office. 
Classification Classification assigned to the patent by the 
Patent Office. See chapter 3.2 for details. 
Referenced Patents The number of existing patents that are 
referred, including classes and subclasses.  
Abstract Invention’s summary. Appears on the front 
page and is the most referenced section. 
Drawings Black and white drawings of the invention. 
Background of the invention Prior Art. It is an explanation of previous 
inventions that can be related to the new 
one. 
Summary of the Invention Discussion that captures the essential 
features and functions. 
Brief Description of Drawings Usually one sentence in order to explain the 
drawings of the invention. 
Detailed Description of the Preferred 
Version of the Invention 
A more exhaustive discussion of the aspects 
of the invention. 
Claims The legal scope of the patent. 
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There are several different routes for protection. The inventor - an individual, 
company, public body, university, etc. has to choose one route according to the strategy they 
want to follow. The basic option is a national route, where an application is filled with a 
national patent office. Another option is to follow an international route where applicants can 
protect their inventions in more than one country. Applicants can also choose to apply only to 
a regional office, for example, they can apply to the European Patent Office (EPO) which grants 
European patents. The validation process requires both translations into the national language 
of each country and the payment of national fees. After being granted, the patent can be 
challenged by third parties. They can request legally for a patent to be revoked or deemed 
invalid and the applicant has also the right to enforce the disputed patent in court. This process 
is purely national, including in Europe [50].  
 
3.2 CLASSIFICATION  
To facilitate search, patents are classified according to technical area. According to 
Montecchi and colleagues [51], different patent offices have their own patent classification 
systems, being the major ones presented in table 3.2. 
 
Table 3-2 - Different patent classification systems and correspondent issuing offices. Adapted from [51] 
Patent Classification Systems Issuing Office 
International Patent 
Classification (IPC) 
World Intellectual Property Organization (WIPO); 
 
European Classification* EPO 
In Computer Only (ICO)* EPO 
United States Patent 
Classification (USPC) 
United States Patent and Trademark Office (USPTO) 
F-Index* Japanese Patent Office (JPO) 
F-term JPO 
* derived from IPC 
 
As we can see in table 3.2, there are many distinct classifications that have several 
differences between them. In order to overcome this problem, EPO and USPTO decided to 
create a new classification system, the Cooperative Patent Classification (CPC) [52]. CPC is 
divided into nine sections, from A to H and Y, which are also divided into classes, sub-classes, 
groups and sub-groups. It covers 250 000 classes, being the most precise classification that uses 
English Versions [53]. In table 3.3 the different sections and the correspondent designations 
are shown. 
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Table 3-3 - Sections of CPC according to EPO. Available on [53]. 
A Human Necessities 
B Performing Operations, transporting 
C Chemistry,  metallurgy  
D Textiles, paper 
E Fixed Constructions 
F Mechanical engineering, lighting, weapons, blasting engines or pumps 
G Physics 
H Electricity 
Y General tagging of new technological developments; general tagging of cross-sectional 
technologies spanning over several sections of the IPC; technical subjects covered by 
former USPC cross-reference art collections [XRACs] and digests 
 
  
These classifications exist in order to describe, in few words, the invention that is being 
considered and can be used to search documents. The classification process, held by patent 
officers, consists of assigning a patent classification code to the patent. Each code has a 
defined description. As previously mentioned, it follows a hierarchical model with different 
levels, beginning in the most general to the most specific. An example of classification is given 
in table 3.4 in order to better understand how these levels work [51].  
 
Table 3-4 - Example of Classification using CPC. Available on [51] 
Level Level Name Code  Description 
1st Section B Performing Operations; Transporting 
2nd Class B08 Cleaning 
3rd Sub-Class B08B Cleaning in general; prevention of 
fouling in general 
4th Main-group B08BB003/00 Cleaning by methods involving the 
use or presence of liquid or steam 
5th Sub-group – 1 dot B08BB003/04 .Cleaning involving contact with 
liquid 
6th Sub-group – 2 dot B08BB003/10 ..with additional treatment of the 
liquid or of the object being 
cleaned, e.g. by heat, by 
electricity, by vibration  
7th Sub-group – 3 dot B08BB003/12 ...by sonic or ultrasonic vibrations … 
 
 
3.3 PATENT ANALYSIS MOTIVATION  
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3.3.1 PATENT ANALYSIS AND INNOVATION 
According to the Organisation for Economic Co-Operation and Development (OECD), 
innovation is defined as [10]: “(…) the transformation of an idea into a tradable product or 
service, a new manufacturing or distribution process, or a new way of providing service”. They 
further state that technological innovation is [54]: “(…) all of the scientific, technological, 
organisational, financial and commercial steps, including investments in new knowledge, which 
actually, or are intended to, lead to the implementation of technologically new or improved 
products and processes.”  
Therefore, the innovation process is potentiated with the creation and development of 
innovative ideas, which are the precursors of commercial success [47]. It also plays a major 
role in the development of the economy and in sustaining the growth of a world that has an 
increasingly growing population, demanding more resources and that faces several 
environmental challenges [55]. The incentive for innovation becomes evident and it is believed 
that patents can potentially help in this process  [56]. Equally, patents have been also broadly 
used as indicators due to their widespread availability [57], being helpful in identifying both 
technological information and present condition of technology assets [43]. Therefore, patent 
analysis is one of the most used methods to inquire about technological innovation [12].  
For companies, it becomes extremely necessary to study their own patent portfolio 
once the value of knowledge is in part related to the value of patents. According to Grimaldi 
and colleagues [56], this value depends on the context and tries to meet business’ needs 
namely: 
- Employees’ Motivation; 
- Customers’ Attraction; 
- Partners’ Attraction; 
- Investors’ Attraction; 
- Competitors’ Intimidation; 
- Income Generation. 
Although their work is intrinsically related to obtaining strategic information from 
patents, they also state the importance of patent studies in assessing the value of technological 
innovation alongside with information about investments, economic returns, scientific research 
and results. Lee and colleagues [43] refer that patent analysis is able to establish a company’s 
technology strategy by providing information about technology assets, support planning based 
on the knowledge of competitors’ patent portfolio and help managers prioritize the 
development  of projects. Besides technologic strategies, Kim and Lee [58] state that patent 
analysis has been used for both long-term and short-term purposes like monitoring technology 
trends and assess technology innovation patterns. Markatou and Vetsikas [59], sum up the 
21 
 
advantages and disadvantages of patent analysis. Regarding advantages, they refer the 
proximity that exists between patents and innovative activities, the range of fields covered 
and the geographical scope. As stated before, they also point out the easy accessibility of 
patents which enables several different types of analysis, for example, technological, sectoral-
industrial or national. Comparing to other data sources, patents are often considered to be the 
only timely measure of rapid technological change and are extremely important in the 
assessment of technological systems’ performance [59]. On the other hand, the data presented 
by patents has some limitations too. The first one is related to the fact that not every invention 
is patented. Other forms of protecting new products or inventions are available. For example, 
companies can choose to trade secrets instead of patents. In spite of being treated as equals, 
not every single patent has an economic or technological impact and they might differ 
according to the country, sector, technologies, etc. These differences can alter the analysis 
results in terms of performance, being hard to define if we are comparing similar patents or 
not. It is widely accepted that there are several differences between the different patent 
systems due to legal variations and geographic, economic and cultural factors.  
Patents also present an innovation trade-off. In one hand, by the grant of a 
geographical monopoly, patents encourage the exploitation of new inventions, on the other 
hand they have high costs associated (mostly related to maintenance fees and potential 
litigations). A patent gives an exclusive use of a certain technology or method to a company, 
allowing that company to charge higher prices, simultaneously excluding customers that would 
only be capable of paying the marginal cost of the innovative good [50]. According to the OECD, 
this is considered to be the central dilemma created by patents: they foster innovation, growth 
and value creation improving the dynamic efficiency of the economy, however, they also create 
a sort of static efficiency driven by the reduced competition and, consequently, higher prices 
which exclude some of the potential customers. Thus, public policies have been put in place 
to address this dilemma such as the time limit of a patent, its breadth and the compulsory 
licensing mechanisms foreseen in the Trade Related Aspects of Intellectual Property (TRIPS) 
Agreement [50].  
Ultimately, patent analysis can provide answers to many different questions allowing 
to understand which companies are present in the industry, what are the countries where 
innovation in the sector is being performed, what is the potential of R&D, etc [10]. Based on 
the answers to these questions, different aspects of the dynamics of the innovation process 
can be mapped, such as co-operation in research, technology diffusion across countries or 
industries alongside with studies of the competitive process [11]. 
Patent data may also be combined with other data (e.g. scientific publications, 
innovation surveys) according to the stage of innovation being addressed in table 3.5. 
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Table 3-5 - Different measures for innovation. Adapted from [11]. 
Stage of Innovation Cycle Measures 
 
 
Technology Development 
 
R&D expenditures 
and personnel 
Scientific publications 
 
Patented inventions 
 
 
 
Technology diffusion 
 
Patenting activity 
 
International trade 
 
 
 
Technology adoption 
 
Licensing surveys 
 
Sales and market 
penetration 
 
Non-technological innovations  
 
Innovation surveys 
 
Therefore, in a constantly changing and financial lucrative market, ensuring the 
competitive advantage using intellectual property is an important piece of a strategic plan for 
major players. Assessing this intellectual property becomes also an important exercise for both 
future and current players [60]. 
 
 
3.3.2 CURRENT METHODS IN PATENT ANALYSIS 
Usually, patent analysis starts with task identification, that means defining not only 
the goal but also the scope and concepts of the analysis. Then, it is important to build a 
portfolio of patents by searching and filtering the most relevant ones, making a segmentation 
to normalize structured and unstructured items [5]. Usually, patent classification works as a 
filter in the search process, so it becomes essential to select the right and most relevant 
classification categories to the object in analysis. Furthermore, it is unanimous among patent 
researchers that any patent search can be considered as complete [51].  
In order to perform a serious research, the most relevant techniques must be applied. 
The preferred method is a combination of both classification and keyword search. When 
separated these methods have several disadvantages. For instances, keyword search is usually 
performed in English. As such, this may mean that we can be overlooking patents that are 
poorly translated into English – note that, in the US, almost 40% of the applicants are from 
foreign countries. Equally, the same term can have multiple synonyms and sometimes the titles 
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and abstracts are not ideal. There is also some mistakes and omissions that may hinder the 
search by keywords. On the other hand, classification search can suffer due to obsolete 
classifications and minimal classification. It’s important to refer that the classifying process 
can, sometimes,  be rather subjective and incomplete, which decreases the accuracy of this 
search method too [61]. 
 Different databases are available to search patents in order to build a solid search 
result. Some examples are Espacenet, that offers access to millions of patents worldwide, 
dating from 1836 to today [62], USPTO, an American database that has a collection of patents 
from 1790 [63], Google Patents, WIPO, among others. After having the patent result, an analysis 
of each patent and group of patents should be performed, based on patent characteristics. It 
is possible, then, to obtain a patent map and to interpret the results, predicting trends or 
relations inside the sector in analysis [64]. In order to analyze patents’ data, different 
methodologies like text-mining, network analysis, citation analysis and index analysis can be 
used [43]. Lee and colleagues [19], used text mining with component analysis, in order to 
obtain keyword vectors. Then, they performed a vacancy analysis to define areas that have a 
lower patent density but are large in size. These areas were then studied to understand the 
kind of technological features associated and, consequently, the potential for innovation. 
Another text-mining example is the work of Tseng and colleagues [64] that describes some 
techniques that can be used in patent analysis including text segmentation, summary 
extraction, feature selection, term association, cluster information, topic identification and 
information mapping. The main goal of this study was to uncover and visualize useful patterns 
in textual data [65]. Lee and Lee [12], developed patent maps, after selecting patents from 
the analyzed sector – energy sector. Then they developed clusters according to similarities in 
technologies in order to study the evolution of innovation over time in that sector. Kang [66] 
made an empirical study by analyzing different patent information. The study started by 
considering international patent information important to establish marketing strategies and 
to assess information about the geographical distribution of the innovation process in the sector 
(smartphones). Then, the grant ratio was also analyzed as a measurement of patent’s quality 
in the sector. Co-applicants and co-inventors were considered important once resources and 
competencies are dispersed among organizations and in the geographical space. At last, 
knowledge accumulation (as the proportion of citations of the patents filled  by the same 
applicant) and spillover (as the proportion of citations of the patents filled by another 
applicant) were analyzed.   
Visualization techniques help in presenting the results and interpreting them. Many 
different representations can be used such as 2-D matrix, folder trees or topic maps (topics are 
clusters of information obtained through patent analysis). Regarding maps, they can focus on 
trends, showing how topics grow and evolve over time, they can be query maps showing the 
patents which satisfy specific conditions, aggregation maps showing results based on a specific 
tribute or zooming maps showing in detailed a part of the overall map [64].  
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In order to summarize the different tasks, table 3.6 is presented with a typical patent 
analysis scenario starting with task identification and ending in the interpretation of the 
obtained information. 
 
Table 3-6 - Patent analysis scenario. Adapted from [64]. 
Task Identification Define scope; concepts and purposes for the analysis 
Searching Search, filter and download relevant patents 
Segmentation Segment, clean and normalize the different data 
Abstracting Analyze the patent content summarizing claims, topics, functions 
or technologies 
Clustering Group or classify patents 
Visualization Create technology-effect matrices or topic maps 
Interpretation Predict trends and relations 
 
In terms of research topics, both the studies performed and the indicators used 
resorting to patent data analysis are quite diverse. They can vary according to the publication 
format, the approach taken and the questions that are being addressed. According to the OECD 
Patent Statistics Manual [50], patent data can be used to study a diversity of topics, including: 
- Technological Performance– Patents help in the process of tracking 
technological leadership or positioning in a specific sector. 
- Emerging Technologies – The information present in patents helps to identify 
issues such as the involvement of different entities or how innovation is 
performed. 
- Knowledge diffusion and the dynamics of technical change – Patents provide a 
detailed description of how the invention was made alongside with a study of 
previous related inventions. 
- Geography of invention – As patents can be divided according to the country or 
region where they are granted, patent data can be used to study geographical 
characteristics of the innovation process or the impact of a certain regional 
technological specialization. 
- Economic value of inventions – There is a correlation between the value of a 
patent and the number/quality of its citations. By linking the invention to the 
firm’s data, it is possible to extrapolate information about the economic impact 
of a patent. 
- Role of universities in technological development – Similar to the economic 
value of inventions, a compilation of the number of patents filed by universities 
can give information about the impact that they have in technological 
development. 
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- Globalization of R&D activities – Patents have information regarding the 
inventive performance and companies’ activities. It is possible to track the 
different trends of the collaboration between inventors in different countries. 
- Companies’ patenting strategy – Through the information present in patents, it 
is possible to trace the market strategy of the company that owns the patent. 
- Effectiveness of the patent system – Patent data can be used to study the 
impact of the patent system on both inventions and diffusion.  
- Forecasting patent applications – With data complied over time, it is possible 
to predict the future demand for patents. 
 
 
3.4 THE USE OF PATENTS IN THE WMD INDUSTRY 
According to the theory of disruptive innovations [13], there are two different types of 
innovations: sustaining and disruptive. The first ones are those who occur regularly and are 
adopted by a wide range of companies in order to improve the performance of an existing 
product or service. On the other hand, disruptive innovations occur with less frequency and 
tend to have some sort of performance problems in the first moments. This group can further 
be divided into new market and low-end disruptions. New markets are created when the 
characteristics of the product limit the number of potential clients, one example is the creation 
of personal computers. Low-end disruptions are those which influence the low-end of the 
original business, attracting customers. One example is the entrance of the Korean automakers 
into the American market – a new market wasn’t created but several customers where 
attracted (those who couldn’t afford the product before).  
In the case of wearable technologies, they have been around for many years. Yet, they 
are highly priced and are cumbersome [13]. Therefore, the wearable device market is 
considered to be in a critical point due to lack of adoption by early majorities to existing 
products. The market itself is constantly changing, caused by a quick technology growth, which 
makes the entrance in this sector even harder. It becomes necessary to study the innovation in 
this sector, in order to understand in which point it stands and what kind of opportunities are 
not being exploited.  
According to Giuseppe and colleagues [22], the market’s interest in this kind of 
solutions is expected to be enormous. The technological developments can potentially provide 
competitive advantage so patents are both valuable and relevant to this issue. It is worth noting 
that the number of patents related to wearable devices has increased in recent years, as we 
can see in figure 3.1. They further state that wearables are at the beginning of the transition 
from research to the commercialization phase, with a relevant number of units sold in order to 
support their integration into the clinical practice and healthcare processes. 
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In spite of not being specific to the case of WMDs, as stated before, it is possible to 
predict trends in this sector comparing to the overall market for wearables. Due to the 
relevance that patents have in innovation, it becomes evident the interest of their use in order 
to understand the dynamics of this industry.  
 
 
 
3.4.1 PATENT LANDSCAPE ANALYSIS OF WEARABLE TECHNOLOGIES 
According to LexInnova [60], wearable technology patents in the field of healthcare 
and medical devices score the highest number of applications. Top assignees for patents in the 
wearable fields are companies like Microsoft and Phillips, however, the top assignees for 
medical devices are Medtronic, Philips and Dexcom. Regarding geographical coverage, United 
States of America shows the highest number of patent applications followed by China. North 
America is considered to be the largest market for wearable devices, comprising over than 40% 
of global sales.  
In a review of the intellectual property rights in the specific field of both wearable 
sensors and systems, Giuseppe and Piccini [22] searched for several different patents with 
specific keywords such as “wearable”. They restricted the search to specific IPC groups. For 
example, they consider the group A61B5 that is related to “Human Necessities” (Section A), 
“Medical or veterinary Science; Hygiene” (Class A61), “Diagnosis; Surgery; Identification” and 
specifically “Diagnosis; Psycho-physical tests”(Subclass A61B) and “Detecting, measuring or 
recording for diagnostic purposes” (Group A61B5). They further analyze the evolution of the 
number of patents, alongside with geographical distribution and top assignees. Their 
conclusions are aligned with those of Lexinnova, i.e, that United States of America has the 
highest number of granted patents and that the top assignees are companies like Philips. 
Figure 3-1- Number of patents related with wearables since 1990 until 2013. Available on  [5]. 
Figure 3-2- Number of patents related with wearables since 1990 until 2013. Available on  [5]. 
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4. METHODOLOGY 
This study was based on a set of 495 companies with potential interest in wearable 
technologies.  Of this initial dataset a selection  of  the  ones  commercializing both wearable 
and ECG products was made. This selection was performed by analyzing each of the companies’ 
website and its respective product portfolio. If any of the products had an ECG sensor 
incorporated, then the company would be selected. Both medical and fitness/well-being 
devices were considered. Of the previously selected companies, an exhaustive analysis was 
further performed in order to understand whether  the commercialize products were, in some 
way, legally protected by patent claims. So, in this phase, the focus was on companies’ patent 
portfolio and the relation between claims and product features. 
 
4.1 PRELIMINARY COMPANY STUDY 
This study was based on a set of companies with potential interest in wearable 
technologies. These companies were taken from different databases (CB Insights [67], SNS 
Research [68], IDTechEx [69] and Kalorama Information[70]). Due to the various applications 
that wearable medical devices may have the search was narrowed to ECG technologies only.   
In the first stage of the analysis, the database used was Google Patents [71]. This search 
engine allows different types of search fields, such as assignee, inventor, priority date, etc. It 
also allows to search terms that can be present in any part of the patent. Figure 4.1 illustrates 
an example of a search by assignee and keyword search, using the defined keywords: ECG/EKG 
and wearable. It is important to focus on the connectors used. In the case of the keywords ECG 
and EKG, the connector “or” is used because, in this context, the words act as synonyms. In 
the case of the keyword wearable, the connector used is an “and”, because we want the 
presence of both keywords (ECG/EKG and wearable). The patent search was held from February 
2016 to March 2016. It is important to refer that patents are only published 18 months after 
request, meaning that we analyzed patents until October 2014. 
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The search by assignee was performed for every company of the initial set, that can be 
consulted in appendix 8.1 – Companies List. If the company had patents, the keyword search 
was also held, first for each keyword (ECG or synonyms ; wearable), and then for both (ECG or 
synonyms and wearable), as illustrated previously. Companies’ product portfolios were also 
studied. If the company had patents with both keywords and was commercializing products 
with ECG technology, at the time of this study, then it would be selected for a further analysis, 
as shown in figure 4.2. 
 
4.2 PATENTING AND PRODUCT ANALYSIS  
For this second stage of the study, we only considered the set of companies currently 
commercializing wearable ECG products (according to the information on the company’s 
website) and that, simultaneously, were patent applicants with patents containing both 
keywords. 
Figure 4-2-Scheme representing the preliminary stage of this study. 
 
Figure 4-1 - Example of search by assignee (Alivecor) and keyword search. available on [86]. 
Initial set
Companies 
with patents
Companies with 
patents with both 
keywords and 
wearable ECG 
products
29 
 
 In order to filter patents related to ECG products, a new patent search was held. As 
shown in figure 4.3, the method used was a combination of search by assignee and a 
classification search, using CPC codes. In this case, the database used was not Google Patents, 
but Espacenet [72], due to the redundancy of results in Google Patents, i.e., the same patent 
returned more than once.  
 
The used codes are shown in table 4.1 and were chosen due to their relation with ECG. 
The final company set consisted of 15 companies, accounting for a total of 96 patents (see 
appendix 8.2- Patents List). In some cases (Medtronic, Polar Electro, Samsung Electronics), due 
to the high number of returned results a keyword search was also held, alongside with the 
classification search. The chosen keywords were product related and broad enough to minimize 
the potential loss of relevant patents. The keywords used were: 
- Wireless and mobile, in the case of Medtronic; 
- Heart Rate, in the case of Polar Electro: 
- Sensor, in the case of Samsung Electronics.  
 
Table 4-1 - CPC codes used to filter patents 
CPC symbol Designation 
A61B5/0006 Remote monitoring of patient with the measured ECG signals being 
transmitted from the patient to a remote monitor or site 
A61B5/0245 Measuring Heart Rate by using ECG signals 
A61B5/0404 Hand-held or portable   apparatus   for   detecting,   measuring   or 
recording ECG. 
 
Each of the retrieved patents was analyzed in order to understand whether it was 
related to any of the products currently commercialized by the respective company.  Of the 
overall 96 patents, 38 were considered as product related.  
As previously mentioned, in chapter 3, each patent has a set of claims. Espacenet 
allows users to arrange them in a claims tree which enables the visualization of a tree 
representation of the independent claims and their dependent claims [73]. Thus, each 
independent claim of each of the 38 patents was analyzed and matched with a product feature. 
These product features, shown in table 4.2, were defined according to product specifications, 
except for the overall system and signal processing. These two features were considered in 
order to characterize the general architecture and the methods for processing the acquired 
signals, respectively.  
Figure 4-3 - Scheme representing the patenting and product analysis phase of this study. 
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Table 4-2 - Group of features determine to classify each patent claim 
Feature Designation 
Overall System Includes all claims related to product’s components and 
structure, i.e., the way they are arranged.   
Signal Processing Includes all claims related to methods for analyzing and obtaining 
information from acquired signals. 
Data Transmission Includes all claims related to methods and components for data 
transmission. 
 
Performance 
Includes all claims related to input dynamic range, memory 
length, recording format. 
 
Circuitry 
Includes all claims related to frequency response, input 
impedance, A/D sampling rate, resolution, DC offset, CMRR, 
differential range. 
 
Output 
Includes all claims related to modulation, center frequency and 
frequency deviation. 
User Interface Includes all claims that can be related to means of communication 
between the device and user. 
 
In order to match the selected patent claims with product features, we used the Delphi 
method. This method has been widely used to obtain medium or long-term forecasts, which 
involves establishing a consensus from a panel of experts [74]. Our panel included 5 experts in 
electronics, mostly academic researchers in the area of signal processing and a European Patent 
Attorney. Each expert was asked to match the independent claims of each patent with the 
product feature(s) that better characterize what was being claimed. They were given a brief 
explanation about the method and were provided with the patent claims, a link for the patent 
and a link for the product technical description (on the company’s website). The answers of 
each expert were then analyzed and the results shown reflect the consensus obtained by the 
expert panel. When divergences were found, the decision for the product feature classification 
was taken by majority.  
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5. RESULTS 
In this section, the results of both patent analysis and product portfolio analysis are 
shown. First, an overview of the general patent tendency is made, by analyzing which of the 
495 initial companies have patents and their relation with wearable and ECG technologies. 
Then, a more detailed study is performed in order to understand the commercialization of 
patents and their relation with product features. 
 
5.1 PATENT TENDENCY IN THE WEARABLE TECHNOLOGY MARKET 
Of the initial set of 495 companies, acting in the wearable industry, 138 (approximately 
28%) offered products with heart rate monitors, from which 55 (approximately 40%) were ECG 
related. Regarding patenting trends, as shown in figure 5.1, 328 companies have patents, i.e., 
approximately 66%. Of those companies, 119 (approximately 36%) had patents with the keyword 
“wearable”, 36 (approximately 11%) with the keyword “ECG” or “EKG” and 81 (approximately 
25%) with both. Therefore, most of the patents for which the analyzed companies applied 
appear to be related to wearable technologies in general. Nevertheless, there is a significant 
percentage of patents containing both “ECG” and “wearable” keywords in their text.  
160
7
36
119
81
92
328
without patents no information ECG/ EKG wearable both others
Figure 5-1 – Tendency to patent, as well as ECG/wearable patents for the selected wearable technology 
companies. 
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5.2 PATENT ANALYSIS AND PRODUCT PORTFOLIO ANALYSIS  
For the next stage, the 81 companies that had patents with both “ECG” (or synonyms) 
and “wearable” as keywords were reviewed. The focus was exclusively on companies that 
already were commercializing ECG wearable products at the moment of this study since the 
main goal was to understand whether the inventions were  already incorporated in  commercial 
products. 
 In order to evaluate ECG-related patents only, a new patent search was held for each 
of these companies as applicant, combining it with the considered CPCs (see 4. Methodology). 
Similarly to the process followed by Andreoni [22], this approach allowed us to not only include 
patents with  “ECG” (or synonyms) as keyword, but also the patents that could be related to 
these terms. Both these conditions were met by 15 companies of the initial sample, which 
accounted for 96 patents. In figure 5.2, it is possible to see the total number of patents of the 
15 selected companies and the number of patents after narrowing the search with the selected 
CPC codes.  
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Figure 5-2 - Total number of patens vs patents with defined CPC codes used for the classification search. 
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Afterwards, the products technical specifications were analyzed. For each of the 96 
patents, we checked, through “patent pending” mentions on the products information (e.g., 
website, instructions manual, figures on the patent body) whether the invention described in 
them was already implemented in the respective product. Two different groups were obtained 
- commercialized patents (i.e., patents protecting inventions that were implemented into a 
commercialized product) and not commercialized patents. The first group consisted on a set 
of 38 patents, and the later 58 patents. These results are presented in figures 5.3 and 5.4. In 
figure 5.3, we present the trend for commercialization, based on the priority date of the 
patent, for these two different groups; while in figure 5.4 it is represented the 
commercialization tendency for each analyzed company. 
The results do not show a clear trend for commercialization vs. priority date. Looking 
at all 96 patents, it is possible to see that only 38 (approximately 40%) are actually implemented 
into products. This trend is consistent even if we only consider patents with priority date from 
2010 onwards. When analyzing the results in terms of patent age, the tendency of patenting 
wearable ECG devices increased through the years, alongside with an increased tendency of 
patenting product features. Nevertheless, in 2012 there was a peak of the number of patents 
that were not related to any kind of product, followed by an increase in the number of patents 
implemented in products in 2013.  
When addressing patent commercialization status by company, having in consideration 
the portfolio dimension according to the used CPC codes, it is possible to note that 6 out of 15 
companies have more than 50% of their patent portfolio currently implemented in a commercial 
product. In fact, for the considered company sample, the average commercialization rate is 
58% per company (with a standard deviation of 33%), accounting for the great dispersion that 
is exhibited in Figure 5.4. 
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Figure 5-3 - Tendency through the years (1990-2014) of the commercialization of patents. 
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In order to understand the product features that the patents were claiming, for the set 
of 38 patents that were commercialized, a correspondence between claims and product 
features was made using a panel of experts, according to the category definition present in 
Table 4.2. A total of 158 claims were analyzed. The obtained distribution can be found in figure 
5.5. 
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Figure 5-5-Correspondence between features and claims. 
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 As shown, most claims tend to be broad enough in order to protect the products’ 
components, structure and the way they are arranged (i.e., overall system). Such claims add 
up to 57% of all claims present in commercialized patents. After the overall system, signal 
processing and circuitry are the two areas with higher patent tendency (22%) followed by user 
interface (13%), data transmission (11%), output (8%) and, finally, performance characteristics 
(4%). As previously stated, it is important to mention that the same claim can have multiple 
classifications, i.e., it can refer to different product features.  
When analyzing the distribution of the relationship of patents claims/product features 
and companies, it is possible to note a similar patent trend regarding the protection of product 
features. According to figure 5.6 and 5.7, companies, individually, also have a higher tendency 
to patent the overall system. 6 out of 15 companies have more than 50% of their patent claims 
related to this feature followed by signal processing, circuitry and output features. Figure 5.6 
shows an average of the claimed product features per company. Figure 5.7 shows the 
distribution of claimed product features per company. It is interesting to see that every 
company has claims related with the overall system, but only two companies present claims 
related to output characteristics. Moreover, given the importance of data transmission in a 
system such as a wearable, not every company presented patents related to this feature.  
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Figure 5-6 - Average of claimed product features per company. For each company, the percentage of 
each claimed feature was taking into consideration and then an average was calculated in order to 
understand the distribution per company. 
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Figure 5-7 - Distribution of product features per company. Notice that Polar OEM also refers to one of the products of Polar Electro too.
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6. DISCUSSION 
6.1 WEARABLES AND PATENT TENDENCY 
In this study, it is evidenced that the majority of the analyzed companies acting in the 
wearable industry has patents in their portfolio. Having focused on ECG, a widely used measure 
in healthcare, our study points towards the fact that the wearable medical devices are, in fact, 
in line with the medical devices industry, also protecting through patents the technological 
breakthroughs that will originate products [75]. However, why are companies patenting their 
inventions? According to Blind and colleagues [76], there are different approaches in order to 
justify this tendency and can be related to offensive or defensive strategies. Companies patent 
defensively in order to prevent other firms from patenting their inventions or even to block 
other market participants of using some sort of technologies. In the other hand, firms can 
patent offensively to prevent or block other firms from patenting inventions that are similar to 
their own inventions and which they intend to commercialize. If this is the case, the company 
will try to build a much broader patent wall when compared to a defensive patenting. This can 
prevent other firms from commercializing competing products [77].  
In further analysis, we also show that the majority of patents are, in some way, related 
to wearable technologies. This result is expected since the company set was based on market 
studies and databases related to wearable technologies. Nevertheless, there is also a significant 
percentage of patents related with ECG.  In order to obtain these insights, a keyword search 
was used. The effectiveness of this type of search is directly related to the selected keywords 
for retrieval [78]. In this stage, the keywords chosen were simple and broad enough in order to 
include every related patent. They were searched in every section of the patent text, contrarily 
to existing methodologies that strict their search to specific sections such as title, abstract or 
claims [78]. The reason for this is the fact that, in this part of the study, the goal was to obtain 
a general analysis and a preliminary selection of companies that operate in the specific area 
of wearable ECG technologies, so the search was not narrowed to any specific part of the 
patent. However, the retrieved results had to be further analyzed as some of them could not 
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be particularly meaningful (e.g. the keyword was used only as a description of prior art to show 
an example of previous applications). 
By combining the patent analysis with the product portfolio analysis, we show that 
around 60% of the considered patents are not currently incorporated into commercial products. 
As the companies analyzed are currently still in business (or were acquired by other 
companies), and as over 50% of the analyzed patents has a priority date from 2010 onwards, it 
is unlikely that these inventions were already implemented in a product that is now out of the 
market. Also, due to the regulatory process, product development cycles in medical devices 
are quite long. Therefore, these facts point out in the direction that patents that are not 
commercialized may yet not be in the market, as products that incorporate them may be under 
development. An analysis of these patents could have the potential to show what kind of ECG 
wearable products we will have in the market in the next few years.  
It is interesting to note that 10 of the 15 analyzed companies have 510k approval, not 
necessarily related to an ECG product. This shows that the majority of companies is, in some 
way, acting in the medical device sector, since this approval is a regulatory path that allows 
the commercialization of this type of devices [79]. However, not every analyzed product can 
be considered a medical device, since they don’t have any type of regulatory approval. Even 
so, this does not validate the exclusion of other devices (targeted for the fitness and wellbeing 
market), since they have the potential to be later approved as a medical device. By considering 
them, the scope of products we analyzed is wider and can produce more meaningful results. 
Additionally, a recent study by CBInsights [80],shows that the interest in WMDs is increasing 
when compared with devices targeted for the fitness market, so it will be expected that in the 
future these companies will seek regulatory approval in order to be able to perform in the 
medical industry also.  
Further analyzing each individual company, the patent tendency is higher than 50%. 
There are some examples of companies (e.g. OMSignal) that have all the patents 
commercialized. Other companies have only the selected patents (with at least one of the 
defined CPC codes) commercialized (e.g. bOMDIC, Textronics). In this case, companies have 
more patents, but were not selected due to the search by classification (this is possible to see 
by analyzing the graphic of figure 5.6). It is also interesting to note that every company of the 
final set (of 15 companies) has at least one of the select patents exploited in one of its 
products. This fact evidence, once more, that companies are interested in protecting their own 
inventions, exercising either for offensive or defensive strategies.   
Regarding the evolution over time, as stated before in the Results chapter, there is no 
evident trend. The patents that are previous to 1996 are already part of the public domain, 
since the 20 years of protection have already ended. Nevertheless, since 2004 there is always, 
at least one commercialized patent, with a peak in 2013. It is important to emphasize that this 
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was the last full year analyzed, as patents filed in 2014 were public just up to October that 
year. 
 
6.2 PATENT CLAIMS AND PRODUCT FEATURE ANALYSIS 
By combining patent analysis and product portfolio analysis, it was also possible to 
understand what patent claims were actually related to technology in the product itself. While 
most claims appear to be related to the overall system, the results point out that there is still 
a patent vacuum regarding technologies that may impact product characteristics and user 
interfaces, thereby affecting product design. Since WMDs should be adapted to the human body 
and produce reliable results that help patients and physicians to take informed decisions [81], 
it is critical to consider technologies with impact on product design as a key point to ensure 
quality clinical results and patient comfort while using them. In turn, by understanding and 
filling this gap in the patent pool, companies have the potential to influence and accelerate 
the adoption of the wearable devices and their entry in the market. While Jee and Sohn [5] 
derive new product characteristics for wearable devices through a conjoint analysis, a market 
research technique, disregarding the possibility of actually implementing them in a real new 
product, the method proposed in this study uncovers product evolution areas that are 
potentially less patented and where there is still space for innovation.  
The results obtained with this analysis can be interpreted in a number of different 
ways. On one hand, the high number of claims related to the overall system can be a sign that 
companies have a defensive strategy towards other companies. As previously referred, an 
offensive strategy can be characterized by patents with a larger patent portfolio [77]. The 
overall system is a characteristic of the product that can be quite generalist, therefore leading 
to patents with a broader scope. 
Another interesting insight this study generated is that signal processing and circuitry 
are the following product characteristics with a higher percentage of assigned claims. As 
explained before (see 3. Literature Review), the major challenges in building a wearable ECG 
device rely on the development of compact, low power wearable sensors that are able to 
acquire, process and transmit the sensed signals. A high number of signal processing and 
circuitry claims can be a result of research and development efforts of technologies directed 
to such challenges. 
The user interface is an important feature when designing a wearable device. In a world 
where people are overburdened with information and media channels, predictive, contextual 
and relevant information supersedes any functionality a device can offer making designing 
experiences a major challenge [82]. Furthermore, the user interface design of technology 
artifacts has been linked to usage behaviour and, when it comes to wearables, it appears that 
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users tend to easily discontinue their use due to lack of interest [83]. Therefore, it would be 
reasonable to expect the incidence of this feature to be greater, however, it is only of 13% of 
the total set of independent claims. One possible interpretation for this would be that 
companies are not yet focused on user interfaces. However, user interfaces may be somehow 
harder to patent as many of them do not constitute, by themselves, patentable technologies. 
Therefore, the analysis of this issue resorting to our intellectual property rights, such as design 
protection. 
Regarding data transmission, it would be also expected a higher incidence patent 
claims related to this feature, since the transmission of acquired signals is essential to the 
performance of the wearable device. However, this result could be due to the fact that only 
the independent claims were analyzed (the same can be applied to any of the previously 
mentioned features), disregarding information present in dependent claims.  
Finally, there features presenting the lowest incidence in the analyzed claims were 
output and performance characteristics. Although it may be hard to explain this, it can be a 
result of the specificity of these two features. In fact, only two companies have output claims 
and the percentage associated with performance characteristics is extremely low for each 
company. Again, more specific claims are explored in the dependent claims. On the other hand, 
output and performance characteristics can also be an indirect result from technologies related 
to other features, such as signal processing, or circuitry. 
Obviously, product feature-related claims with lower incidence could also mean that 
there is more space for innovation, as it was mentioned. Following this logic, there is a wider 
room for innovation in fields related to output and performance characteristics compared with 
signal processing, circuitry. It is interesting to note that when comparing the general patenting 
tendency with the tendency per company, the results are very similar. This can be the result 
of a similar strategy towards the protection of intellectual property or a convergence of 
companies’ focus when addressing the development of their ECG devices.  
 
6.3 COMBINING PATENT POOLS AND PRODUCT PORTFOLIO ANALYSIS 
– A NEW PATENT ANALYSIS APPROACH 
As previously mentioned in the Literature Review, a typical patent analysis scenario 
involves different tasks, usually starting with task identification followed by the search of 
relevant patents, segmentation, information analysis, clustering of patents and, finally, 
visualization and interpretation [64]. Current methods for performing the different tasks are 
based on different techniques like text-mining, network analysis, citation analysis, index 
analysis, etc [43]. Additionally, current technology forecasting methods also rely mostly on 
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conjoint analysis of patent pools and patent pool visualization methods, disregarding what is 
already in the market – the product portfolio. Therefore, this study introduces a new approach 
in order to combine patent pool analysis and product portfolio. The novelty of this method 
relies on crossing the obtained patents with the products of the companies that are being 
analyzed, uncovering areas for product evolution.  
In order to produce reasonable and meaningful insights, first of all, the method needs 
a good initial set of companies. The number of patents that can potentially be obtained is 
dependent on the companies that explore the market segment in analysis and their magnitude. 
The preliminary analysis is not mandatory, however, as shown, it could help in better 
understand the industry dynamics and select the right companies for the study. The method 
used to select the patents of interest can also be different or even a combination of methods, 
depending on the sample’s extent. In this case of application, a classification search was 
enough to produce meaningful insights about the wearables ECG industry. The CPC codes 
chosen were the ones that can be linked with wearable ECG devices.  
Since the key of this method is crossing patent claims with product features, it is 
important to consult with experts in the area, in order to build a solid group of product 
characteristics. They should characterize the majority of products placed on the market under 
study in order to optimize the classification of each claim. This classification is subjective and 
some sort of validation is an advantage, which, in this study, was achieved through the use of 
one round of experts, which consists of part of the Delphi method, as referred in the 
Methodology.  
One important limitation of our study is that we only looked into companies that were 
themselves the patent applicant, and therefore, we ignored the possibility of patent licensing 
among companies. Further analyzing the method and having in consideration what was 
mentioned previously it is evident that it has some drawbacks when compared with traditional 
methods, namely: 
- It is dependent on the company being the applicant, leaving out situations 
where the applicant and the company commercializing the product – the 
licensee – is not the same [84]. This situation was addressed by checking the 
assignee of the patent, however, it could be troublesome in industries where 
licensing activity is important; 
- It is mostly manual, making it more time consuming.  
- an expert in the technical area under analysis is necessary, not only to define 
the product’s characteristics, but also to classify correctly all claims; 
- It can be subjective, depending on the expert that is using it; 
- The initial company set has to be reliable, meaning that it needs to consist of 
companies that develop solutions to the industry in study; 
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- It only looks to the independent claims, leaving the dependent claims for 
analyzing. 
Nevertheless, as shown before, this method is able to produce useful insights when 
applied to specific industries. By using it, it was possible to shed some light into what features 
are currently being patented, what is the focus of companies and what was  the evolution over 
time.  
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7. CONCLUSIONS AND FUTURE 
IMPROVEMENTS 
This study shows that the combination of patent analysis and product portfolio analysis 
is a complimentary method that can give insights about innovation in a specific sector. By 
applying it to the case of ECG wearable products, it was possible to understand if the existing 
patents are being applied to a product and the commercialization tendency through the years. 
By analyzing patent claims, it was possible to determine which the focus of companies when 
patenting a product is. We also uncover areas that can deliver short-term indications for new 
products. Therefore, one of our main conclusions is that companies in the wearable industry 
show a high tendency to patenting in the wearable technology market. For the studied 
companies that presented patents related with wearable ECG technologies, the majority of the 
analyzed patents are not yet incorporated in commercialized products, which can be a result 
of the regulatory process and the development cycle of wearable devices. As the majority of 
the analyzed claims are related to the overall system, it appears that there is less freedom to 
operate in features related to the overall system and more freedom to operate in features 
related to performance characteristics and outputs. In terms of patenting strategy, these 
companies appear to be following an offensive strategy – a high number of patents with broad 
scope. 
Besides the contribution towards technological development in the wearable ECG area, 
this study also contributed to the analysis of patents from a market point of view. While the 
proposed method indeed allows insights on highly patented product features and opportunities 
towards technology development and product innovation, it has drawbacks, such as the time 
it takes, the dependence of the company being the applicant and subjectivity in the claims 
classification, as it is dependent on the expert panel. The generation of a thorough initial 
dataset of companies is also critical for the results. 
Further studies could be performed in order to improve the method and the results 
obtained through it. For instance, the dependent claims could also be analyzed. This would 
allow a broader scope which could lead to more precise results. It would also be interesting to 
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analyze the relationship between the company’s dimension and its patent tendency, studying 
if there is any correlation between the number of patents and its position in the market. To 
better support and validate the presents theories, interviews to companies that work in the 
area could also be performed. This would help in understanding their strategy and focus, 
validating the assumptions about the obtained results. This method also disregards the value 
of the patent, giving the same weigh to every patent. In fact, each patent as a different impact, 
so it would be useful to study the technological and economic impact of both commercialized 
and not commercialized patents, in order to understand if there is any tendency that correlates 
value with patent exploitation. Last, the patent set of uncommercialized patents should also 
be analyzed in order to understand the type of products that might derive from the inventions 
they are protecting. This could have important implications for technological forecasting and 
competition analysis. 
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8. APPENDICES 
8.1 COMPANIES LIST 
Empresa ECG? Patents? KW ECG ? KW wearable? Both? 
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AdhereTech  No Yes No No No 
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AirType No No No No No 
AliveCor Yes Yes Yes Yes Yes 
Amazon No Yes No Yes No 
Ambit Networks No No No No No 
AMD (Advanced Micro Devices) No Yes Yes Yes No 
Amiigo No Yes No Yes No 
Amulyte No No No No No 
Animas No Yes No Yes No 
Apple No  Yes Yes Yes Yes 
APX Labs No Yes No Yes No 
ARA (Applied Research Associates) No Yes No Yes No 
Archos No Yes No No No 
ARM Holdings No No No No No 
Asahi Kasei Group Yes Yes No No No 
53 
 
ASUS (ASUSTeK Computer) No Yes No No No 
ASX No No No No Nºao 
AT&T Mobility No Yes No Yes No 
Atellani No No No No No 
Atheer Labs No No No No No 
Athos Works No Yes Yes Yes Yes 
Atlas Wearables No Yes Yes Yes Yes 
Augmedix No Yes No Yes No 
Avegant No Yes No Yes No 
Avery Dennison Yes Yes Yes Yes No 
AVG No Yes No No No 
Awarepoint  No Yes Yes No No 
BabyBe  No No No No No 
BAE Systems No Yes No Yes No 
Baidu No Yes No Yes No 
Barclays No Yes No No No 
Basis Science No Yes Yes Yes Yes 
BeBop Sensors No Yes No Yes No 
Beddit No Yes No Yes No 
Behavioral Technology Group No No No No No 
BI           
BIA Sport Nao No No No No 
Bionym Yes Yes Yes Yes Yes 
Biosensics No Yes No No No 
BioSerenity  No No No No No 
BIT (Blue Infusion Technologies) No Yes No No No 
Bitbanger Labs No No No No No 
BL Healthcare  No No No No No 
Blocks Wearables Yes No No No No 
Bluetooth Special Interest Group No No No No No 
BodyMedia Yes Yes Yes Yes Yes 
bOMDIC Yes Yes Yes Yes Yes 
Boston Scientific Corporation Yes Yes Yes Yes No 
BRAGI No Yes No No No 
Breitling No Yes No No No 
Brilliantservice No Yes No Yes No 
Broadcom No Yes Yes Yes Yes 
Brother Industries No Yes No - No 
Brunel University No Yes No No No 
BSX Atheletics No No No No No 
BSX Insight No No No No No 
BTS Bioengineering No No No No No 
Buhel No Yes No No No 
Cambridge Temperature Concepts No Yes No Yes No 
Carre Technologies Yes Yes Yes Yes Yes 
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Casio Yes Yes Yes Yes Yes 
Catapult Sports No No No No No 
CETEMMSA No Yes No No No 
Chrono Therapeutics  No Yes No No No 
Cisco Systems No Yes No No No 
Citizen No Yes Yes Yes No 
Cityzen Sciences No No No No No 
Clothing+ No Yes Yes Yes Yes 
Codoon No No No No No 
CommandWear No No No No No 
CompeGPS No No No No No 
Compumed Inc.  Yes Yes No No No 
Connect America No Yes No No No 
ConnecteDevice No Yes No No No 
ConnectedHealth  No No No No No 
Control VR No Yes No No No 
Cool Shirt Systems No No No No No 
Covidien Yes Yes Yes Yes Yes 
Creaholic No Yes No No No 
Creoir No Yes No No No 
CSR No Yes No Yes No 
Cue  No         
Cuff No Yes No Yes No 
Cyberdyne No Yes Yes Yes No 
DAQRI No Yes No Yes No 
DARPA  No No No No No 
Dell No Yes Yes Yes No 
Diesel No Yes No No No 
DK Tek Innovations No No No No No 
DKNY No No No No No 
Doppler Labs No Yes No No No 
DorsaVi No Yes No No No 
Dreamtrap Commercials No No - - - 
Dubai Police No No No No No 
Durex No Yes No No No 
E Ink Holdings No Yes No No No 
EarlySense  No Yes Yes Yes Yes 
EB Sport Group No No No No No 
EdanSafe No Yes No No No 
Ekso Bionics No Yes No - No 
Electric Foxy No No No No No 
Electrozyme No Yes No Yes No 
Emotiv Systems No Yes Yes No No 
Enjoy S.R.L No No No No No 
Epson (Seiko Epson Corporation) No Yes Yes Yes No 
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EuroTech No Yes No Yes No 
Evena Medical No Yes Yes Yes Yes 
Everfind No No No No No 
Evermind  No Yes No No No 
Everywear Games No No No No No 
Exelis No Yes No Yes No 
Eyenetra  No No No No No 
EyeTap No No No No No 
Facebook No Yes No Yes No 
FashionTEQ No Yes No Yes No 
Fat Shark No No No No No 
Fatigue Science No Yes Yes Yes Yes 
FDA (U.S. Food and Drug Administration) No No No No No 
Filip Technologies No Yes No Yes No 
Finis No Yes No No No 
FitBark No No No No No 
Fitbit No Yes Yes Yes Yes 
Fitbug No Yes No Yes No 
FitLinxx Yes Yes Yes Yes Yes 
Flextronics No Yes No Yes No 
Flyfit No No No No No 
Force Impact Technologies No No No No No 
Fossil No Yes No Yes No 
Foxtel No No No No No 
Free Wavz No No No No No 
Freescale Semiconductor No Yes No Yes No 
Fruit Street  No No No No No 
Fujitsu No Yes Yes Yes Yes 
Garmin No Yes Yes Yes No 
GE Healthcare Yes Yes Yes No No 
GEAK No No No No No 
Gemalto No Yes No Yes No 
General Dynamics Corporation No Yes - No No 
General Dynamics Mission Systems No No No No No 
GEO Group No Yes No No No 
Geopalz No No No No No 
Georgia Institute of Technology No Yes No No No 
GestureLogic No Yes No Yes No 
Ginger.io No Yes No Yes No 
Given Imaging No Yes No Yes No 
GlassUp No Yes Yes Yes No 
Glofaster No No No No No 
GlucoVista  No Yes No Yes No 
GN Netcom No Yes No Yes No 
GN Store Nord No Yes No - No 
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Google Yes Yes  Yes Yes No 
GoPro No Yes No No No 
GOQii No No No No No 
Gucci No Yes No No No 
Guess No Yes No No No 
Halo Neuroscience No No No No No 
HealBe No Yes No No No 
Hello  No Yes Yes Yes Yes 
HereO No Yes No No No 
Hollywog No Yes No No No 
Honeywell International No Yes Yes Yes No 
House of Horology No No No No No 
Hovding No Yes No Yes No 
HP Yes Yes Yes Yes No 
HTC No Yes Yes Yes Yes 
Huami Technology No Yes No No No 
Huawei No Yes  Yes Yes Yes 
i.am+ No Yes No Yes No 
i’m SpA No No No No No 
i4C Innovations No Yes Yes Yes No 
IAMAS  No No No No No 
ICEdot No No No No No 
ICON Health and Fitness No Yes Yes No No 
IDENTEC GROUP No Yes No No No 
iHealth Lab No No No No No 
iLOC Technologies No Yes No Yes No 
Imagination Technologies No Yes No No No 
Imec Yes Yes Yes Yes Yes 
Immerz No Yes No No No 
Ineda Systems No Yes No Yes No 
InfinitEye No No No No No 
Infobionic Yes Yes Yes Yes Yes 
Innovega No Yes No No No 
Instabeat No No No No No 
Intel Corporation No Yes Yes Yes Yes 
InteraXon No Yes No Yes No 
InteraXon (Muse) No No No No No 
InvenSense No Yes Yes Yes Yes 
Iotera No Yes No No No 
iRhythm Yes Yes Yes Yes Yes 
Iron Will Innovations No Yes No Yes No 
ITAMCO  No No No No No 
ITT Corporation No Yes No No No 
Jabra No Yes No Yes No 
Jan Medical  No Yes Yes No No 
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Jawbone No Yes No No No 
Jaybird No Yes No Yes No 
Johnson & Johnson No Yes No Yes No 
Johnson & Johnson Innovations No No No No No 
Kairos Watches No Yes No Yes No 
Kapture No No No No No 
Ki Performance No No No No No 
Kinsa  Yes Yes No Yes No 
Kiwi Wearable Technologies No No No No No 
KMS Solutions No No No No No 
KoruLab No Yes No No No 
Kreyos No No No No No 
Kronoz No No No No No 
L-3 Communications No Yes No Yes No 
L-3 Mobile-Vision No Yes No Yes No 
Lark Technologies No Yes Yes Yes Yes 
Laster Technologies No No No No No 
LeapFrog Enterprises No Yes No No No 
Lechal No No No No No 
Ledong Information Technology No No No No No 
Lemonade Lab No No No No No 
Lenovo No Yes No Yes No 
LG Electronics No Yes Yes Yes Yes 
LifeBEAM No Yes No No No 
LifeLogger Technologies Corporation No No No No No 
Limmex No Yes No Yes No 
Liquid Image No Yes No No No 
Little Labs No No No No No 
Lockheed Martin No Yes Yes Yes No 
LogBar No Yes No Yes No 
LOSTnFOUND N No No No No 
Loughborough University No Yes No Yes No 
Lumafit No No No No No 
Lumo BodyTech No Yes No No No 
Lumus No Yes No Yes No 
Luxottica No Yes No  Yes No 
Mad Apparel No Yes Yes Yes Yes 
Magellan (MiTAC Digital Corporation) No Yes No No No 
Magic Leap No Yes No Yes No 
Martian Watches No No No No No 
Matilde           
MC10  Yes Yes Yes Yes Yes 
McLear No Yes No Yes No 
mCube No Yes No No No 
MediaTek No Yes Yes Yes No 
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Medtronic Yes Yes Yes Yes Yes 
Melon No No No No No 
Memi No Yes No Yes No 
META No Yes No Yes No 
Meta Watch No Yes No Yes No 
Microsoft No Yes Yes Yes Yes 
Mindray Medical International Limited  Yes Yes Yes Yes Yes 
MindStream No Yes No No No 
Mio Global Yes No No No No 
Misfit Wearables No Yes No No No 
MiTAC International No Yes No Yes No 
Moff No Yes No No No 
MonDevices No Yes No No No 
Moov No Yes No No No 
Mortara Instrument, Inc.  Yes Yes Yes No No 
Moticon No Yes No No No 
Motion Fitness No No Ñão No No 
Motion Metrics International Corporation No Yes No No No 
Motiv No Yes No Yes No 
Motorola Mobility No Yes Yes Yes Yes 
Motorola Solutions No Yes Yes Yes Yes 
Movable No No No No No 
Mozilla Corporation No No No No No 
Mutalink No No No No No 
Mutewatch No No No No No 
Myontec No Yes No  No No 
Narrative No Yes No Yes No 
Neptune No Yes No  Yes No 
Netatmo No Yes No No No 
NeuroPro No Yes No No No 
Neurosky Yes Yes Yes Yes Yes 
Neurovigil  No Yes Yes No No 
New Balance Yes Yes No Yes No 
Nihon Kohden Corporation  Yes Yes Yes Yes Yes 
Nike No Yes Yes Yes Yes 
Nintendo No Yes Yes Yes Yes 
Nissan No Yes Yes Yes Yes 
Nixie Labs No Yes No Yes No 
Nixon No Yes No Yes No 
Nod No Yes No Yes No 
Nokia No Yes Yes Yes Yes 
Notch Interfaces No No No No No 
Novasom  No No No No No 
NTT DoCoMo No Yes Yes Yes Yes 
Nuance No Yes Yes Yes No 
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Nuubo Yes No No No No 
NVIDIA Yes Yes No Yes No 
NZN Labs No No No No No 
Obaa  No No No No No 
Oculus VR No Yes No No No 
ODG (Osterhout Design Group) No Yes No Yes No 
Ohmatex No No No No No 
Olio Devices No Yes No Yes No 
Olive Labs           
Omate No No No No No 
Omega No Yes No Yes No 
OMG Life No No No No No 
Omron No Yes Yes Yes Yes 
OMsignal Yes Yes Yes Yes Yes 
Opening Ceremony No Yes No Yes No 
Optalert No Yes No No No 
Optinvent No Yes No No No 
Orange No Yes Yes Yes Yes 
OrCam Technologies No Yes No Yes No 
OriginGPS No Yes No No No 
Orion Labs (OnBeep) No No No No No 
Orpyx Medical Technologies No Yes Yes No No 
O-Synce No No No No No 
Owlet Baby Care No No No No No 
Palomar Health No No No No No 
Panasonic No Yes  Yes Yes Yes 
Paris Miki Holdings No Yes No No No 
Parvus No Yes No No No 
Pebble Technology No Yes No Yes No 
Pepsi No Yes No No No 
Perceptive Devices No Yes No Yes No 
Performance Sports Group No No No No No 
Perpetua Power Source Technologies No Yes Yes Yes Yes 
PFO Tech No No No No No 
Philips Yes Yes Yes Yes Yes 
PHTL (PH Technical Labs) No Yes No No No 
Phyode No No No No No 
Pivothead No No No No No 
Pixie Scientific No Yes No Yes No 
Plantronics No Yes No Yes No 
Playtabase No Yes No Yes No 
PNI Sensor Corporation No Yes No No No 
Polar Electro Yes Yes Yes Yes Yes 
Polyera No Yes No Yes No 
Pragmasystems No No No No No 
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Preventice Yes No No No No 
Pristine  No         
Proteus Digital Health No Yes Yes Yes Yes 
PST Sensors No Yes No No No 
PUSH Design Solutions No Yes No No No 
Qardio Yes Yes Yes Yes Yes 
Qualcomm Yes* Yes Yes Yes Yes 
Quanttus No Yes No Yes No 
Ralph Lauren Corporation No Yes No No No 
Raytheon No Yes Yes Yes Yes 
Razer No Yes No Yes No 
Recon Instruments No Yes No Yes No 
Reebok International No Yes Yes Yes Yes 
Rest Devices No Yes No No No 
Revolutionary Tracker No No No No No 
RHLvision Technologies No No No No No 
Ringblingz No No No No No 
Ringly No Yes No No No 
Royal Philips Healthcare Yes No No No No 
RSL Steeper Group No Yes No No No 
Rufus Labs No No No No No 
S3 ID No Yes No No No 
Salesforce.com No Yes No Yes No 
Salutron Yes Yes Yes Yes Yes 
Samsung Electronics Yes Yes Yes Yes Yes 
Sano Intelligence  No Yes No No No 
Sarvint Technologies No No No No No 
Scanadu  Yes Yes Yes Yes Yes 
Schiller AG  Yes Yes Yes No No 
Secret Labs No No No No No 
Seiko No Yes Yes Yes Yes 
SenseCore Yes No No No No 
Sensegiz Technologies No Yes No No No 
Senseonics  No Yes Yes Yes No 
Sensible Baby No No No No No 
Senso Solutions No No No No No 
Sensoplex No No No No No 
Sensoria No Yes Yes Yes Yes 
Sentimoto No No No No No 
Seraphim Sense No Yes No Yes No 
Shanda Group No No No No No 
Shimmer Yes Yes No No No 
ShotTracker No Yes No No No 
Sigmo No No No No No 
Silent Alert Monitor  No Yes No Yes No 
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Yesplifeye  No No No No No 
SITA No No No No No 
Skully Systems No No No No No 
Smart Device (SmartQ) No Yes No No No 
Smarty Destination Technology   No No No No 
Smarty Ring No No No No No 
SMI (SensoMotoric Instruments) - Yes Yes No No 
SMS Audio No Yes No No No 
Snaptracs No No No No No 
Somaxis Yes Yes Yes Yes Yes 
Sonitus Medical No Yes Yes Yes Yes 
Sonostar No No No No No 
Sony Corporation No Yes Yes Yes Yes 
Sony Mobile Communications No Yes Yes Yes No 
Sotera Wireless Yes Yes Yes Yes Yes 
Soundbrenner No No No No No 
Spacelabs Healthcare Inc.  Yes No No No No 
SparkPeople No No No No No 
Spire No Yes No No No 
Sports Beat No No No No No 
SpotNSave No No No No No 
Spree Wearables No No No No No 
Sproutling No Yes No Yes No 
Sqord No Yes No No No 
Stalker Radar (Applied Concepts) No Yes No No No 
STATSports No No No No No 
STMicroelectronics No Yes Yes Yes Yes 
Stretchsense No Yes No Yes No 
Striiv No Yes No No No 
SunFriend Corporation No Yes No Yes No 
Sunsprite  No No No No No 
Survios No No No No No 
Suunto No Yes Yes Yes Yes 
sWaP           
Swatch Group No Yes No Yes No 
T.Ware No Yes No No No 
Tag Heuer No Yes No No No 
Tarsier No No No No No 
TASER International No Yes Yes No Yes 
TCL Communication No Yes Yes Yes Yes 
Technical Illusions No Yes No No No 
Teletracking  No Yes Yes No No 
Textronics Yes Yes Yes Yes Yes 
Thalmic Labs No Yes Yes Yes Yes 
The Walt Disney Company No Yes No Yes No 
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Theatro No Yes No No No 
Thync No Yes Yes Yes Yes 
TI (Texas Instruments) Yes Yes Yes Yes Yes 
Timex Group No Yes Yes Yes Yes 
Tissot No No No No No 
TLink Golf No No No No No 
TN Games No No No No No 
Tobii Technology No Yes No Yes No 
Tomoon Technology No No No No No 
TomTom No Yes No Yes No 
Tory Burch No No No No No 
Touch Bionics No Yes No No No 
TrackingPoint No Yes No No No 
TuringSense  No No No No No 
Two Tin Cans No No No No No 
U.S. Department of Defense No No No No No 
U-blox No Yes No No No 
Under Armour No Yes Yes Yes No 
Universities of Glasgow No Yes Yes Yes Yes 
University of Leeds No Yes Yes No No 
University of Reading No Yes No Yes No 
University of Strathclyde - Yes No Yes No 
Uno           
Valencell No Yes Yes Yes Yes 
Validic (Motivation Science) No No No No No 
Vancive Medical Technologies No Yes No No No 
Vergence Labs No No No No No 
Victoria’s Secret No Yes No No No 
Vigo No No No No No 
Virgin Atlantic No Yes No No No 
VitalConnect  Yes No No No No 
Vivalnk Yes Yes Yes Yes No 
Voluntis  No Yes Yes No No 
VSN Mobil No No No No No 
Vuzix No Yes No Yes No 
Wahoo Fitness No Yes No Yes No 
Wather Enterprises - No No No No 
We:eX (Wearable Experiments) No Yes No No No 
Wearable Intelligence No Yes No Yes No 
Weartrons Labs No No No No No 
Welch Allyn  Yes Yes Yes Yes Yes 
Wellograph No No No No No 
Whistle No Yes No Yes No 
Whoop  No  Yes Yes Yes Yes 
Wirecard No Yes No No No 
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Withings No Yes Yes No No 
WTS (Wonder Technology Solutions) No No No No No 
X-Doria (Doria International) No No No No No 
Xensr No No No No No 
Xiaomi No Yes No Yes No 
XO Eye Technologies No No No No No 
XOWi No No No No No 
Xybermind No Yes No No No 
Ybrain No Yes No Yes No 
Yingqu Technology No No No No No 
Zackees No Yes No Yes No 
Zeiss (Carl Zeiss) No Yes Yes Yes No 
Zephyr Technology Yes Yes Yes Yes Yes 
Zepp Labs No Yes No No No 
Zinc Software No Yes Yes No No 
Zoll Medical Corporation Yes Yes Yes Yes Yes 
ZTE No Yes Yes Yes Yes 
 
8.2 PATENT LIST 
Empresa Title 
AliveCor METHODS AND SYSTEMS FOR CARDIAC MONITORING WITH MOBILE DEVICES AND ACCESSORIES   
AliveCor METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING   
AliveCor SMARTPHONE AND ECG DEVICE MICROBIAL SHIELD   
AliveCor UNIVERSAL ECG ELECTRODE MODULE FOR SMARTPHONE   
AliveCor UNIVERSAL ECG ELECTRODE MODULE FOR SMARTPHONE   
AliveCor Apparatus for Coupling to Computing Devices and Measuring Physiological Data   
AliveCor TWO ELECTRODE APPARATUS AND METHODS FOR TWELVE LEAD ECG   
AliveCor TWO ELECTRODE APPARATUS AND METHODS FOR TWELVE LEAD ECG   
AliveCor CARDIAC PERFORMANCE MONITORING SYSTEM FOR USE WITH MOBILE COMMUNICATIONS DEVICES  
AliveCor ELECTROCARDIOGRAM SIGNAL DETECTION   
AliveCor ULTRASONIC TRANSMISSION OF SIGNALS   
AliveCor Personal monitoring device, ECG device and smart phone protection box   
AliveCor WIRELESS, ULTRASONIC PERSONAL HEALTH MONITORING SYSTEM   
AliveCor HEART MONITORING DEVICE USABLE WITH A SMARTPHONE OR COMPUTER   
bOMDIC STAMINA MONITORING METHOD AND DEVICE 
Casio MOTION INFORMATION DETECTION APPARATUS, MOTION INFORMATION DETECTION METHOD (...)  
Casio CARDIOTACHOMETER AND ITS ATTACHMENT METHOD   
Casio CARDIOTACHOMETRY DEVICE AND OPERATION METHOD OF THE SAME   
Casio Measurement of electrocardiographic wave and sphygmus 
Casio Exercise level of difficulty data output apparatus   
Medtronic SYSTEM AND METHODS FOR WIRELESS BODY FLUID MONITORING   
Medtronic Wireless cardiac pulsatility sensing  
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Medtronic Skin-mounted electrodes with nano spikes   
Medtronic SYSTEM FOR DYNAMIC REMOTE NETWORKING WITH IMPLANTABLE MEDICAL DEVICES  
Neurosky Mobile cardiac health monitoring   
OMSignal TEXTILE BLANK WITH SEAMLESS KNITTED ELECTRODE SYSTEM   
Polar Electro Transfer of Measurement Data Related to Physical Exercise   
Polar Electro TRANSFER OF MEASUREMENT DATA RELATED TO PHYSICAL EXERCISE  
Polar Electro SENSOR SYSTEM, GARMENT AND HEART RATE MONITOR   
Polar Electro Screen   
Polar Electro Wrist-worn device   
Polar Electro Method of monitoring human relaxation level, and user-operated heart rate monitor  
Polar Electro Method and device for measuring heart rate, and method for manufacturing the device  
Polar Electro Calibration of performance monitor   
Polar Electro Method and apparatus for measuring heart rate   
Polar Electro Method of performing operating settings in heart rate measurement arrangemen (...)  
Polar Electro Method and arrangement for heartbeat detection   
Polar Electro Electrode belt of heart rate monitor  
Polar Electro Connecting arrangement at heart rate monitor and electrode belt   
Polar Electro Heart rate monitor, method and computer software product  
Polar Electro Integral heart rate monitoring garment   
Polar Electro Electrode structure integrated into a belt for measuring a person's heart rate has a contact surface (...)  
Sotera Wireless BODY-WORN MONITOR FOR MEASURING RESPIRATORY RATE   
Sotera Wireless SYSTEM FOR MEASURING VITAL SIGNS USING BILATERAL PULSE TRANSIT TIME   
Sotera Wireless BODY-WORN VITAL SIGN MONITOR   
Sotera Wireless OPTICAL SENSORS FOR USE IN VITAL SIGN MONITORING  
Sotera Wireless BODY-WORN PULSE OXIMETER  
Sotera Wireless SYSTEM THAT MONITORS PATIENT MOTION AND VITAL SIGNS   
Sotera Wireless VITAL SIGN MONITORING SYSTEMS  
Sotera Wireless HAND-HELD VITAL SIGNS MONITOR   
Sotera Wireless BODY-WORN SENSOR FEATURING A LOW-POWER PROCESSOR AND (...) 
Sotera Wireless BODY-WORN MONITOR FOR MEASURING RESPIRATORY RATE  
Sotera Wireless BODY-WORN VITAL SIGN MONITOR   
Sotera Wireless BODY-WORN VITAL SIGN MONITOR   
Textronics TEXTILE-BASED ELECTRODE   
Zoll Medical Corp WEARABLE AMBULATORY MEDICAL DEVICE WITH MULTIPLE SENSING ELECTRODES   
Zoll Medical Corp ELECTROCARDIOGRAM IDENTIFICATION  
Zoll Medical Corp RESCUE PERFORMANCE METRIC  
Zoll Medical Corp VCG VECTOR LOOP BIFURCATION 
Zoll Medical Corp RESUSCITATION ENHANCEMENTS  
Zoll Medical Corp TRANSMITTING TREATMENT INFORMATION   
Zoll Medical Corp SELECTION OF OPTIMAL CHANNEL FOR RATE DETERMINATION   
Zoll Medical Corp INTEGRATED RESUSCITATION APPARATUS AND METHOD INCLUDING PERFUSION MONITOR  
Zoll Medical Corp METHOD OF MEASURING ABDOMINAL THRUSTS FOR CLINICAL USE AND TRAINING   
Zoll Medical Corp RESCUE PERFORMANCE METRICS FOR CPR AND TRAUMATIC BRAIN INJURY  
Zoll Medical Corp Real-Time Evaluation of CPR Performance 
Zoll Medical Corp WEARABLE MEDICAL TREATMENT DEVICE WITH MOTION/POSITION DETECTION  
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Zoll Medical Corp RESCUE SCENE VIDEO TRANSMISSION 
Salutron INTEGRATED SENSOR MODULES   
Salutron CLIP ADAPTOR FOR AN ACTIVITY MONITOR DEVICE AND OTHER DEVICES   
Salutron Energy Expenditure Computation Based On Accelerometer And Heart Rate Monitor  
Salutron PULSE WIDTH CODING WITH ADJUSTABLE NUMBER OF IDENTIFIER PULSES BASED ON CHANGE IN HEART RATE  
Salutron PULSE WIDTH CODING FOR INTERFERENCE-TOLERANT TELEMETRIC SIGNAL DETECTION   
Salutron HEART RATE MONITOR WITH CROSS TALK REDUCTION 
Salutron Electrostatic Discharge Protection For Wrist-Worn Device   
Salutron Electrostatic discharge protection for analog component of wrist-worn device   
Salutron EKG based heart rate monitor with digital filter and enhancement signal processor   
Samsung 
Electronics Electrocardiogram Watch Clasp   
Samsung 
Electronics METHOD AND APPARATUS FOR MEASURING THE DIFFERENCE OF PULSE WAVE VELOCITY IN MOBILE DEVICE   
Samsung 
Electronics ELECTROCARDIOGRAM SENSOR AND SIGNAL PROCESSING METHOD THEREOF   
Samsung 
Electronics FUNCTION OPERATING METHOD BASED ON BIOLOGICAL SIGNALS AND ELECTRONIC DEVICE SUPPORTING THE SAME 
Samsung 
Electronics WEARABLE BODY SENSOR AND SYSTEM INCLUDING THE SAME   
Samsung 
Electronics METHOD FOR PROCESSING DATA, SENSOR DEVICE AND USER TERMINAL  
Samsung 
Electronics WEARABLE DEVICE AND MANAGING DEVICE FOR MANAGING A STATUS OF USER AND METHODS THEREOF   
Samsung 
Electronics METHOD AND APPARATUS FOR RECOGNIZING IDENTIFICATION IN PORTABLE TERMINAL USING TOUCHSCREEN 
Samsung 
Electronics APPARATUS AND SENSOR OF MEASURING BIO SIGNAL, APPARATUS AND(...)  
Samsung 
Electronics CARD TYPE HANDHELD TERMINAL FOR MEASURING PHYSIOLOGICAL SIGNAL  
Samsung 
Electronics Apparatus and method for attaching biosignal measurement sensor to subject  
Samsung 
Electronics Portable device having biosignal-measuring instrument  
Samsung 
Electronics Method, medium, and apparatus measuring biological signals using (...)  
Zephyr Technology SYSTEM METHOD AND DEVICE FOR MONITORING A PERSON'S VITAL SIGNS   
Scanadu Inc PORTABLE DEVICE WITH MULTIPLE INTEGRATED SENSORS FOR VITAL SIGNS SCANNING  
Scanadu Inc PORTABLE DEVICE WITH MULTIPLE INTEGRATED SENSORS FOR VITAL SIGNS SCANNING  
Infobionic Inc SYSTEMS AND METHODS FOR DISPLAYING PHYSIOLOGIC DATA 
Infobionic Inc REMOTE HEALTH MONITORING SYSTEM   
Mc10 CONFORMAL SENSOR SYSTEMS FOR SENSING AND ANALYSIS OF CARDIAC ACTIVITY   
Mc10 ELECTRONICS FOR DETECTION OF A CONDITION OF TISSUE  
  
 
 
8.3 PRODUCTS LIST 
Empresa Produtos 
AliveCor AliveCor Mobile ECG 
bOMDIC GoMore 
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Casio Phys 
Medtronic Seeq MCT 
Textronics (Adidas) Numetrex 
OMSignal 
OM Bra 
OM Smart Shirt 
Zephyr 
Bioharness 3 
HxM Smart 
Polar 
H7 HR Sensor 
For Manufacturers 
Sotera Wireless Visi Mobile 
Zoll Medical Coportation LifeVest 
Salutron 
lifetrak 
S Pulse 
Samsung Electronics Bio Processor 
Scanadu Incorporated Scanadu Scout 
Infobionic MoMe 
MC10 biostamp 
 
 
 
 
